Brief: Devyser's NGS Products For Monitoring Of Kidney And Stem Cell Transplanted Patients Receive IVDR Approvals
July 17 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* DEVYSER DIAGNOSTICS AB - DEVYSER'S NGS PRODUCTS FOR
MONITORING
OF KIDNEY AND STEM CELL TRANSPLANTED PATIENTS RECEIVE IVDR
APPROVALS
Source text for Eikon: ID:nPn4bzT6Ta
Further company coverage: DVYSR.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue